Animal Parasiticides Market by Type [Ectoparasiticides (Pour-ons & Spot-ons, Tablets, Sprays, Dips, Ear Tags, Collars, Others), Endoparasiticides (Oral Liquids, Oral Solids, Injectables, Feed Additives, and Others), and Endectocides], Animal Type (Companion Animal and Livestock Animals), and End User (Veterinary Clinics & Hospitals, Animal Farms, and Home Care Settings): Global Market Size Estimates and Forecast (2022-2030)

Code: BMIRE00026439 | Pages: 100 | Industry: Biotechnology | Date: Sep 2022 | Type: Global

The market crossed US$ 9.56 billion mark in 2022 and is expected to hit US$ 15.85 billion by 2030, recording a CAGR of 6.5% during the forecast period. 

Animal parasiticides market has been significantly growing with the increasing growth of Ectoparasiticides segment.

Increasing adoption of companion animals in developing countries is one of the major factors driving growth of the animal parasiticides market. For instance, according to American Society for the Prevention of Cruelty to Animals approximately 4.1 million shelter animals are adopted each year (2 million dogs and 2.1 million cats). Additionally, it is estimated that 78 million dogs and 85.8 million cats are owned in the US. Thus, the increasing population of companion animals and rising pet ownership in developed countries are also expected to support the growth of animal parasiticides market during the forecast period. The ectoparasiticides segment is expected to pace up with the growing issues and concerns with pet animals. Further, other segment such as endoparasiticides and endectocides is also expected to gain traction during the forecasted year.

Within the report, the market is segmented into type, animal type, and geography. By type, the market is further segmented into ectoparasiticides, endoparasiticides, and endectocides. On the basis of ectoparasiticides, the market is subsegmented into pour-ons & spot-ons, tablets, sprays, dips, ear tags, collars, and others. By endoparasiticides, the market is sub-categorized into oral liquids, oral solids, injectables, feed additives, and others. Based on animal type, the market is divided into companion animal and livestock animals. Based on end user, the market is divided into Veterinary Clinics & Hospitals, Animal Farms, and Home Care Settings. Geographically, the animal parasiticides market is subsegmented into North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa.

Get more information on this report :

Increasing investments by private players empowered the growth of futuristic innovations.

With the continuous awareness and rising concerns over zoonotic diseases, the animal health market rapidly grown in recent years. The industry has attracted huge investments from leading market players, mainly due to the growing demand in the animal parasiticides market for effective drugs. According to the European International Federation of Animal Health, major players spend 12% of their annual sales on R&D activities, while 6% of annual sales are invested in R&D activities by small and medium players. Of the total R&D expenditure, around 35% is spent on defensive R&D to keep existing products in the market.

Emerging livestock industry is one of the major factors accelerating the market growth.

The industries for animal parasiticides are the animal health, livestock industry, poultry industry, leather industry, and others. Within these industries, livestock industry is one such industry, wherein the use of animal parasiticides is increasing for better animal health and their products. For instance, according to the National Dairy Development Board, milk production in India has increased every year—from 176.3 million tons in 2018 to 198.4 million tons in 2020. The poultry industry is also encouraging the use of parasiticides as poultry animals are more prone to parasitic diseases

Recent strategic developments in animal parasiticides market

The animal parasiticides market has undergone several significant developments, and a few of these have been mentioned below:

  • In June 2021, Boehringer Ingelheim partnered with Lifebit (UK) to detect global infectious disease outbreaks using AI and natural language processing technology.
  • In August 2020, Elanco Animal Health Incorporated (US) acquired Bayer Animal Health (Germany) for USD 6.89 billion to expand its scale and capabilities in the animal health industry.
  • In August 2021, Zoetis Inc. (US) acquired Jurox (Australia) to expand its product portfolio and manufacturing capacity with potential for global expansion.
  • In August 2020, Merck & Co., Inc. (US) acquired worldwide rights of Vexocan brand of parasiticide from Elanco Animal Health for the ruminant’s portfolio.
  • In August 2019, Elanco purchased Bayer animal healthcare business, making Elanco second largest player in the veterinary pharmaceutical market. The acquisition aimed at improving Elanco’s position in the veterinary market by expanding its product portfolio and strengthening its market position.

 

The animal parasiticides market is driven by several players by implementing strategic activities such as investments, new launches, mergers & acquisitions, and partnerships. Zoetis Inc.; Elanco Animal Health Incorporated; Virbac; Merck & Co., Inc.; Boehringer Ingelheim GmbH; Ceva Santé Animale; Vetoquinol S.A.; PetIQ, Inc.; Norbrook; and Bimeda Animal Health are among the prominent players operating in the market.

 

Target audience for the report:

  • Raw material providers
  • Animal parasiticides manufacturers
  • Animal health-related service providers
  • Parasiticides-related associations, organizations, forums, and alliances
  • Government bodies, such as regulating authorities and policy makers
  • Venture capitalists, private equity firms, and start-up companies
  • Animal parasiticides distributors and sales firms
  • End users of animal parasiticides
  • Research institutes, organizations, and consulting companies
  • Animal health organizations

 

Scope of the report:

In this report, the market has been segmented on the basis of:

  • Type:
    • Ectoparasiticides
      • Pour-ons & Spot-ons
      • Tablets
      • Sprays
      • Dips
      • Ear Tags
      • Collars
      • Others

 

    • Endoparasiticides
      • Oral Liquids
      • Oral Solids
      • Injectables
      • Feed Additives
      • Others
    • Endectocides

 

  • Animal Type
    • Companion Animal
    • Livestock Animals

 

  • End User:
    • Veterinary Clinics & Hospitals
    • Animal Farms
    • Home Care Settings

 

  • Region
    • North America
    • Europe
    • Asia Pacific (APAC)
    • South & Central America
    • Middle East & Africa

 

  • Companies profiled
    • Zoetis Inc.
    • Elanco Animal Health Incorporated
    • Virbac
    • Merck & Co., Inc.
    • Boehringer Ingelheim GmbH
    • Ceva Santé Animale
    • Vetoquinol S.A.
    • PetIQ, Inc.
    • Norbrook
    • Bimeda Animal Health

Companies profiled
- Zoetis Inc.
- Elanco Animal Health Incorporated
- Virbac
- Merck & Co., Inc.
- Boehringer Ingelheim GmbH
- Ceva Sant? Animale
- Vetoquinol S.A.
- PetIQ, Inc.
- Norbrook
- Bimeda Animal Health

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$2000
Site License
$3000
Enterprise License
$4000